I. Guenther

发表

Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection.

E. Chow, Weixin Hou, T. Toh, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects

Koen Van Laere, Guy Bormans, Michel Koole, 2008, Journal of Nuclear Medicine.

A pilot study of dual-isotope lymphoscintigraphy for breast sentinel node biopsy comparing intradermal and intraparenchymal injection.

R. Barber, A. Purushotham, L. Bobrow, 2009, European Journal of Surgical Oncology.

Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model.

P. Low, B. Connolly, Shubing Wang, 2013, Molecular pharmaceutics.

Synthesis of 2‐[18F]fluoro‐3‐[2(S)‐2‐azetidinylmethoxy]pyridine, a highly potent radioligand for in vivo imaging central nicotinic acetylcholine receptors

C. Crouzel, F. Dollé, H. Valette, 1998 .

[76Br]Bromodeoxyuridine PET in tumor-bearing animals.

K. Leenders, H. Blattmann, U. Roelcke, 2001, Nuclear medicine and biology.

Measurement of the extraction fractions of nanocolloid and polyclonal immunoglobulin by axillary lymph nodes in patients with breast cancer

R. Barber, A. Purushotham, J. Ballinger, 2004, Nuclear medicine communications.

Preliminary evaluation of 2-[4-[3-tert-butylamino)-2-hydroxypropoxy]phenyl]-3-methyl-6-me thoxy-4(3H)-quinazolinone ([+/-]HX-CH 44) as a selective beta1-adrenoceptor ligand for PET.

C. Crouzel, F. Dollé, H. Valette, 1999, Nuclear medicine and biology.

Ex Vivo Imaging of Pancreatic Beta Cells using a Radiolabeled GLP-1 Receptor Agonist

E. Hostetler, B. Connolly, R. Hargreaves, 2012, Molecular Imaging and Biology.

Comparison of the InVivo Distribution of Four Different Annexin A 5 Adducts in

E. Hostetler, C. Reutelingsperger, H. Mehmet, 2014 .

Comparison of the In Vivo Distribution of Four Different Annexin A5 Adducts in Rhesus Monkeys

E. Hostetler, C. Reutelingsperger, H. Mehmet, 2011, International journal of molecular imaging.

Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A.

K. Leenders, S. Ametamey, A. Antonini, 1996, Nuclear medicine and biology.

A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.

D. Guilloteau, C. Fuseau, B. Maziére, 1999, Life Science.

Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.

C Crouzel, C. Crouzel, H. Valette, 1999, Journal of medicinal chemistry.

Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A.

C. Lartizien, O. Curet, Y. Bramoullé, 2003, Bioorganic & medicinal chemistry letters.

Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone

O. Curet, Y. Bramoullé, F. Dollé, 2003, Journal of Pharmacology and Experimental Therapeutics.

Early postnatal irradiation‐induced age‐dependent changes in adult mouse brain: MRI based characterization

K. N. Bhanu Prakash, I. Guenther, F. Tang, 2021, BMC neuroscience.

Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.

R. Blasberg, J. Missimer, K. Leenders, 2000, Cancer research.

Radiosynthesis and quality assurance of 5-[124I]Iodo-2'-deoxyuridine for functional PET imaging of cell proliferation.

R. Finn, I. Guenther, J. Koziorowski, 1998, Nuclear medicine and biology.

Imaging central nicotinic acetylcholine receptors in baboons with [18F]fluoro-A-85380.

C Crouzel, C. Crouzel, F. Dollé, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Characterization of the nicotinic ligand 2-[18F]fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine in vivo.

C. Crouzel, F. Dollé, H. Valette, 1998, Life sciences.

In vivo Quantification of Monoamine Oxidase A in Baboon Brain: A PET Study Using [11C]befloxatone and the Multi-Injection Approach

M. Grégoire, J. Delforge, O. Curet, 2010, Journal of Cerebral Blood Flow and Metabolism.

Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors.

S. Larson, P. Zanzonico, R. Finn, 2002, Nuclear medicine and biology.

Simplified estimation of binding parameters based on image-derived reference tissue models for dopamine transporter bindings in non-human primates using [18F]FE-PE2I and PET.

B. Gulyás, Chang-Tong Yang, C. Halldin, 2017, American journal of nuclear medicine and molecular imaging.

In vivo quantification of myocardial dihydropyridine binding sites: a PET study in dogs.

C. Crouzel, F. Dollé, H. Valette, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantitation of Extrastriatal D2 Receptors Using a Very High-Affinity Ligand (FLB 457) and the Multi-Injection Approach

Bernard Bendriem, André Syrota, Michel Bottlaender, 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

In vivo Quantification of Monoamine Oxidase A in Baboon Brain: A PET Study Using [11C]befloxatone and the Multi-Injection Approach

M. Grégoire, J. Delforge, O. Curet, 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects

G. Bormans, K. Goffin, P. Rothenberg, 2008, Journal of Nuclear Medicine.